Related Experiment Videos
Deoxyribonucleases activities in human leukemic cells and mouse lymphoblasts.
Cancer Letters
|November 1, 1975
Summary
Deoxyribonuclease activity in lymphocytes differs between healthy and leukemic cells. Treatment restores neutral deoxyribonuclease activity and reduces acid deoxyribonuclease activity in leukemia patients.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Deoxyribonucleases (DNases) are enzymes crucial for DNA metabolism.
- Alterations in DNase activity are implicated in various diseases, including cancer.
- Human lymphocytes and mouse leukemic cells (L5178Y) serve as models for studying cellular DNase profiles.
Purpose of the Study:
- To compare deoxyribonuclease (DNase) activities in human lymphocytes, acute lymphocytic leukemia (ALL) cells, and mouse L5178Y leukemic cells.
- To investigate the impact of medical treatment on DNase patterns in leukemia.
Main Methods:
- Micro-disc-electrophoresis for separating cellular proteins.
- In situ detection of deoxyribonuclease activity within DNA-containing polyacrylamide gels.
- Comparative analysis of DNase profiles between normal, leukemic, and treated cells.
Main Results:
- A specific neutral deoxyribonuclease activity was absent in untreated leukemic cells (both human ALL and mouse L5178Y).
- Conversely, acid deoxyribonuclease activities were elevated in leukemic cells compared to normal lymphocytes.
- Medical treatment led to the reappearance of neutral DNase activity and a decrease in elevated acid DNase activities.
Conclusions:
- The observed changes in deoxyribonuclease (DNase) activity patterns are characteristic of leukemia.
- Restoration of neutral DNase activity and normalization of acid DNase levels correlate with effective medical treatment.
- DNase profiling could potentially serve as a biomarker for leukemia diagnosis and treatment response.